Impact of Lazertinib Dose Modification on Effectiveness and Safety

NCT05716672 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Lazertinib

Sponsor

Pusan National University Hospital

Collaborators

[object Object]